Cysto-Conray Ii (Iothalamate Meglumine) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cysto-Conray Ii. Always confirm against the full prescribing information.
100 interactions
Amikacin
Iothalamic acid may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Capreomycin
Iothalamic acid may decrease the excretion rate of Capreomycin which could result in a higher serum level.
Level 2 evidence
Carbamazepine
Iothalamic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Level 2 evidence
Abacavir
Abacavir may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
Level 2 evidence
Aceclofenac
Aceclofenac may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
Level 2 evidence
Acetaminophen
Acetaminophen may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
Level 2 evidence
Acetazolamide
Acetazolamide may increase the excretion rate of Iothalamic acid which could result in a lower serum level and potentially a reduction in efficacy.
Level 2 evidence
Acetylsalicylic acid
Acetylsalicylic acid may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
Level 2 evidence
Aclidinium
Aclidinium may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
Level 2 evidence
Acrivastine
Iothalamic acid may decrease the excretion rate of Acrivastine which could result in a higher serum level.
Level 2 evidence
Acyclovir
Acyclovir may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
Level 2 evidence
Adefovir dipivoxil
Adefovir dipivoxil may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
Cysto-Conray Ii (Iothalamate Meglumine) has 500 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Cysto-Conray Ii (Iothalamate Meglumine) has 0 major, 19 moderate, and 481 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cysto-Conray Ii. Always confirm against the full prescribing information.